Beimei Pharma focuses on the field of pediatric prescription medicines, headquartered in Shenzhen, China, National High-tech Enterprise, National Science and Technology-based Small and Medium-sized Enterprises, Shenzhen Specialized, Redefined, Differentiated and Innovative Enterprise, Shenzhen Innovative Small and Medium-sized Enterprise. Beimei pharmaceutical incorporates R&D, global licensing, manufacture, marketing and distribution, and has more than 30 pediatric products in its portfolio and pipeline, covering the respiratory system, anti-infection (antibacterial), nervous system, digestive system, endocrinology, ENT and other fields.
Beimei Pharma has established long-term partnerships with some outstanding international pharmaceutical companies, including LTS, Medpharm, Cipla, NTC, Sythorn, Deva holding, EMP, Syrimed, Hetero, Dr.Reddy’s etc. and completed over 100 million RMB series A , series B/B+ and Series C financing, which will further support Beimei to be a pioneer in Chinese pediatric field to meet the clinically unmet demand and provide Chinese pediatric patients with products that are with high-quality, good tasting and can be accurately administrated.
